Physician profile
Azhar Pasha
NPI 1770531337
$3,993.01
in general payments reported to CMS, 2019-2025
22 companies · $1,070 in 2025
The $1,070 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $643 · 2020: $1,159 · 2021: $105 · 2022: $56.28 · 2023: $224 · 2024: $736 · 2025: $1,070.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,109 · Travel and Lodging: $920.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,109.46 |
| Travel and Lodging | $919.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,007.97 | 2019-2025 | Proclaim, Eterna, Prodigy |
| Boston Scientific Corporation | $1,001.27 | 2019-2024 | |
| Si-Bone, INC. | $849.74 | 2025 | |
| Vertiflex, INC. | $261.22 | 2019 | |
| Stimwave Technologies Incorporated | $245.58 | 2019-2020 | |
| Curonix LLC | $99.55 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biodelivery Sciences International, INC. | $64.48 | 2019 | |
| Nevro Corp. | $61.05 | 2019-2024 | Senza |
| Vertos Medical, INC. | $52.22 | 2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $47.84 | 2019-2020 | |
| Medtronic, INC. | $41.44 | 2023-2024 | Microstream, Intellis Adaptivestim |
| Vertex Pharmaceuticals Incorporated | $37.50 | 2024-2025 | |
| Piramal Critical Care | $35.64 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.78 | 2019 | |
| Biotronik Nro, INC. | $26.45 | 2025 | Prospera |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $25.25 | 2025 | Vyrsa V1 |
| Nalu Medical, INC. | $23.08 | 2022 | |
| Forte Bio-Pharma LLC | $22.34 | 2024 | Prolate, Nalocet |
| Valinor Pharma, LLC | $20.50 | 2025 | Movantik |
| Pfizer INC. | $14.93 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.55 | 2019 | |
| Daiichi Sankyo INC. | $10.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Azhar Pasha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.